A unique combination of Bioiberica’s CS BioActive® chondroitin sulfate and Boswellia serrata standardised to 30% acetyl-11-keto-beta-boswellic acid (AKBA). Chondroitin BioActive may help slow the progression of mild osteoarthritis of the knee, as well as provide temporary relief of symptoms including joint swelling, pain and reduced mobility.
Contains scientifically validated Bioiberica’s CS BioActive®chondroitin sulfate and a highly standardised extract of Boswellia serrata (standardised to 30% AKBA) at therapeutic doses per tablet.
Provides 800mg of chondroitin and not less than (NLT) 30% AKBA per one-a-day dose.
Provides nutritional support for the maintenance of healthy joint structure and function.
Helps to slow the progression of cartilage wear and joint space narrowing.
May relieve pain and symptoms associated with mild osteoarthritis.
May temporarily relieve swollen, aching joints and joint inflammation associated with mild arthritis.
May increase joint mobility in mild arthritis.
May help to provide relief of symptoms of plantar psoriasis in people with concomitant knee osteoarthritis when taken daily for three months.
Therapeutic one-a-day dose.
Who is BioCeuticals?
BioCeuticals is Australia’s leading provider of nutritional and therapeutic supplements. Renowned for manufacturing and delivering high quality integrative medicines to healthcare practitioners, BioCeuticals aims to consistently raise the standards of complementary therapies.
BioCeuticals’ vision is to promote complementary and alternative medicines (CAMs) as a key element to Australia’s overall health and wellbeing. Our aim is to develop high quality supplements while maintaining the innovation, integrity and service for which we are renowned.
BioCeuticals has a strong commitment to research, functional formulas and reliable practitioner support. Our supplements are recognised by qualified healthcare practitioners as well as patients; a fact that reflects our reputation as a progressive force in integrative health.
* This website is not intended to report adverse events related to Bioiberica's products. If you would like to report a suspected adverse reaction, please contact the Department of Pharmacovigilance Bioiberica.